CENTER FOR CLINICAL RESEARCH
ACTIVE-3 TICO Trial (NCT04501978)
Therapeutics for Inpatients with COVID-19
ALIVE Trial (NCT02931240)
ANTHEM-HFrEF Pivotal Study (NCT03425422)
AZD 3427 (NCT04630067)
AstraZeneca: A Phase Ia/b Randomized, Single-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of Single Ascending Doses of AZD3427 in Healthy Volunteers and Multiple Ascending Doses of AZD3427 in Patients with Heart Failure (HFrEF and HFpEF)
CardiAMP™ Heart Failure Trial (NCT02438306)
Characterization of Ambulatory NT-proBNP Cut-offs for Patients Possibly Having Heart Failure: CATCH-HF
CHIEF HF Study (NCT04252287)
Canagliflozin: Impact on Health Status, Quality of Life, and Functional Status in Heart Failure
DCM II TRIAL (NCT04476901)
The EXACT Trial (NCT04125732)
The Global cVAD Study (NCT04136392)
The Global cVAD Study will utilize observational data of the ABIOMED, Inc. hemodynamic support devices in real-world settings to drive best practice usage patterns identified through study analysis, to serve as a tool to measure and improve the quality of patient care, and also serve as a resource for future research and regulatory filings.
GORE EXCLUDER (NCT02489539)
Heart FID (NCT03037931)
Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency
The Houston HeartReach Registry is a community-wide registry research study that aims to make improvements in heart disease prevention, diagnosis, and treatment for all women to help identify trends in heart-health risks in a diverse population of women, develop future clinical trials, and recruit women for future research studies.
A study evaluating the efficacy of smaller internal shocks in converting Atrial Fibrillation to normal sinus rhythm in patients undergoing a clinically indicated ablation procedure to avoid unpleasant and potentially painful external shocks, which would otherwise be routinely required.
A clinical investigation to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
PERFORMANCE II Study (NCT04201132)
PORTICO IDE (NCT02000115)
The PORTICO clinical trial is a prospective, multi-center, randomized, controlled clinical study, designed to evaluate the safety and effectiveness of the Portico Transcatheter Heart Valve and Delivery Systems via transfemoral and alternative delivery methods.